Meril Life Sciences today announced one-year results from a pivotal trial evaluating its balloon-expandable Myval THV system.

According to the study’s abstract in The Lancet, TAVR with Acurate neo2 failed to meet non-inferiority. It also resulted in ...

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).

Corsano specializes in advanced real-time remote patient monitoring solutions. Medtronic agreed to exclusively distribute the ...

Auxilium Biotechnologies has enrolled the first patient in a pivotal trial for its NeuroSpan Bridge implant for nerve regeneration.